Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
PREHEVBRIO Pregnancy Outcomes Registry
- Conditions
- Vaccine Exposure During Pregnancy
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06097312
- Locations
- 🇺🇸
ProPharma, Recruiting Nationwide, Overland Park, Kansas, United States
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant
- Conditions
- Coronavirus InfectionsCOVID-19
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- VBI Vaccines Inc.
- Registration Number
- NCT05614245
- Locations
- 🇨🇦
Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada
🇨🇦Red Maple Trials, Ottawa, Ontario, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
- Conditions
- COVID-19Coronavirus Infections
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT05548439
- Locations
- 🇨🇦
Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada
🇨🇦Red Maple Trials, Ottawa, Ontario, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a
- Conditions
- Covid19
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT04773665
- Locations
- 🇨🇦
Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦LMC Manna - Bayview CPU, Toronto, Ontario, Canada
A Bridging Study: Comparing Two Lots of Sci-B-Vacâ„¢ and Engerix-B in Healthy Adults
- Conditions
- Hepatitis B
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 402
- Registration Number
- NCT04531098
- Locations
- 🇻🇳
National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam
- Prev
- 1
- 2
- 3
- Next